THE SICILIAN NETWORK OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY DATA FROM A PROSPECTIVE STUDY ON EFFICACY AND SAFETY

被引：0

作者：

Orlando, A. ^{[1
]}

Fries, W. ^{[2
]}

Privitera, A. ^{[20
]}

Cappello, M. ^{[3
]}

Siringo, S. ^{[4
]}

Inserra, G. ^{[5
]}

Magnano, A. ^{[6
]}

Di Mitri, R. ^{[7
]}

Belluardo, N. ^{[8
]}

Scarpulla, G. ^{[9
]}

Magri, G. ^{[10
]}

Trovatello, A. ^{[11
]}

Carroccio, A. ^{[12
]}

Genova, S. ^{[13
]}

Calandruccio, G. ^{[14
]}

Vassallo, R. ^{[15
]}

Romano, C. ^{[16
]}

Magazzu, G. ^{[17
]}

Citrano, M. ^{[18
]}

Accomando, S. ^{[19
]}

Ventimiglia, M. ^{[1
]}

Renna, S. ^{[1
]}

Orlando, R. ^{[1
]}

Rizzuto, G. ^{[1
]}

Vinci, E. ^{[1
]}

Macaluso, F. S. ^{[1
]}

Cottone, M. ^{[1
]}

机构：

[1] Villa Sofia Cervello Hosp, Div Internal Med, Palermo, Italy

[2] AOU Policlin G Martino, Inflammatory Bowel Dis Unit, Messina, Italy

[3] AOU Policlin G Giaccone, Gastroenterol & Hepatol Unit, Palermo, Italy

[4] ARNAS Garibaldi, Gastroenterol Unit, Catania, Italy

[5] AOU Policlin Vittorio Emanuele, Internal Med Unit, Catania, Italy

[6] AOU Policlin Vittorio Emanuele, Gastroenterol Unit, Catania, Italy

[7] ARNAS Civ Cristina Benfratelli, Gastroenterol & Endoscopy Unit, Palermo, Italy

[8] AO Guzzardi, Gastroenterol Unit, Vittoria, Italy

[9] AOOR S Elia M Raimondi, Gastroenterol Unit, Caltanissetta, Italy

[10] AO Santa Marta & S Venera, Gastroenterol Unit, Acireale, Italy

[11] AO Umberto I, Surg Unit, Siracusa, Italy

[12] AO Giovanni Paolo II, Internal Med Unit, Sciacca, Italy

[13] AO S Antonio Abate, Gastroenterol & Endoscopy Unit, Trapani, Italy

[14] AOOR Papardo Piemonte, Gastroenterol Unit, Messina, Italy

[15] AO Buccheri La Ferla Fatebenefratelli, Gastroenterol & Endoscopy Unit, Palermo, Italy

[16] AOU Policlin G Martino, Genet & Pediat Immunol Unit, Messina, Italy

[17] AOU Policlin G Martino, Pediat Gastroenterol Unit, Messina, Italy

[18] AOOR Villa Sofia Cervello, Pediat Unit, Palermo, Italy

[19] AOU Policlin G Giaccone, Pediat Unit, Palermo, Italy

[20] AO Cannizzaro, Gastroenterol Unit, Catania, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2017年 / 49卷

关键词：

D O I：

10.1016/S1590-8658(17)30329-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OC.06.2

引用

页码：E91 / E91

页数：1

共 50 条

[41] Safety issues with biological therapies for inflammatory bowel disease
Van Assche, Gert
Vermeire, Severine
Rutgeerts, Paul
CURRENT OPINION IN GASTROENTEROLOGY, 2006, 22 (04) : 370 - 376
[42] LONG-TERM SAFETY OF THE SEQUENTIAL USE OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE
Moens, Annick
Ballet, Vera
Sabino, Joao
Vermeire, Severine
Ferrante, Marc
GASTROENTEROLOGY, 2020, 158 (06) : S1257 - S1258
[43] Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial
De Silva, AD
Tsironi, E
Feakins, RM
Rampton, DS
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (11-12) : 1097 - 1105
[44] Elderly patients with inflammatory bowel disease (IBD) are less likely to persist on anti-TNF therapy compared with younger patients: data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
Porcari, S.
Fidanza, O.
Alibrandi, A.
Renna, S.
Cappello, M.
Siringo, S.
Privitera, A.
Inserra, G.
Mocciaro, F.
Magri, G.
Carroccio, A.
Belluardo, N.
Bertolami, C.
Garufi, S.
Ventimiglia, M.
Macaluso, F.
Viola, A.
Cottone, M.
Orlando, A.
Fries, W.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S386 - S387
[45] One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
Amiot, A.
Serrero, M.
Peyrin-Biroulet, L.
Filippi, J.
Pariente, B.
Roblin, X.
Buisson, A.
Stefanescu, C.
Trang-Poisson, C.
Altwegg, R.
Marteau, P.
Vaysse, T.
Bourrier, A.
Nancey, S.
Laharie, D.
Allez, M.
Savoye, G.
Moreau, J.
Vuitton, L.
Viennot, S.
Aubourg, A.
Pelletier, A. -L.
Bouguen, G.
Abitbol, V.
Gagniere, C.
Bouhnik, Y.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (03) : 310 - 321
[46] CLINICAL EFFICACY AND SAFETY OF ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE IN THE ELDERLY
Digby-Bell, Jonathan
Ibraheim, Hajir
Badrulhisham, Fakhirah
Powell, Nick
GUT, 2018, 67 : A75 - A75
[47] Efficacy, safety and durability of anti-TNF therapy in the treatment of inflammatory bowel disease
Trivedi, Chirag
Kao, James
Saxena, Mark
Shen, Eric
Das, Kiron
Ebert, Ellen
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S448 - S448
[48] Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease
Lobaton, T.
Ferrante, M.
Rutgeerts, P.
Ballet, V.
Van Assche, G.
Vermeire, S.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) : 441 - 451
[49] Efficacy and Safety of Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease
Ortega, Triana Lobaton
Vermeire, Severine
Ballet, Vera
Rutgeerts, Paul J.
Van Assche, Gert A.
Ferrante, Marc
GASTROENTEROLOGY, 2014, 146 (05) : S579 - S579
[50] Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study
Herrlinger, K. R.
Diculescu, M.
Fellermann, K.
Hartmann, H.
Howaldt, S.
Nikolov, R.
Petrov, A.
Reindl, W.
Otte, J. M.
Stoynov, S.
Strauch, U.
Sturm, A.
Voiosu, R.
Ammendola, A.
Dietrich, B.
Hentsch, B.
Stange, E. F.
JOURNAL OF CROHNS & COLITIS, 2013, 7 (08): : 636 - 643

← 1 2 3 4 5 →